Literature DB >> 21539623

Development of a new guinea-pig model of shigellosis.

Soumik Barman1, Dhira Rani Saha, Thandavarayan Ramamurthy, Hemanta Koley.   

Abstract

Shigellosis is a major form of bacillary dysentery caused by Shigella spp. To date, there is no suitable animal model to evaluate the protective efficacy of vaccine candidates against this pathogen. Here, we describe a successful experimental shigellosis in the guinea-pig model, which has shown the characteristic features of human shigellosis. This model yielded reproducible results without any preparatory treatment besides cecal ligation. In this study, guinea-pigs were discretely infected with virulent Shigella dysenteriae type 1 and Shigella flexneri type 2a into the cecocolic junction after ligation of the distal cecum. All the experimental animals lost ∼10% of their body weight and developed typical dysentery within 24-h postinfection. In the histological analysis, distal colon showed edema, hemorrhage, exudation and inflammatory infiltrations in the lamina propria. Orally immunized animals with heat-killed S. dysenteriae type 1 and S. flexneri type 2a strains showed high levels of serum immunoglobulin G (IgG) and mucosal IgA antibodies and conferred significant homologous protective immunity against subsequent challenges with the live strains. The direct administration of shigellae into the cecocolic junction induces acute inflammation, making this animal model useful for assessing shigellosis and evaluating the protective immunity of Shigella vaccine candidates.
© 2011 NICED. FEMS Immunology & Medical Microbiology © 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21539623     DOI: 10.1111/j.1574-695X.2011.00810.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  8 in total

Review 1.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  An Experimental Adult Zebrafish Model for Shigella Pathogenesis, Transmission, and Vaccine Efficacy Studies.

Authors:  Debaki R Howlader; Ushasi Bhaumik; Prolay Halder; Aishwarya Satpathy; Sounak Sarkar; Mrinalini Ghoshal; Suhrid Maiti; Jeffrey H Withey; Jiro Mitobe; Shanta Dutta; Hemanta Koley
Journal:  Microbiol Spectr       Date:  2022-05-23

3.  Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo.

Authors:  Christina S Faherty; Christina Faherty; Jill M Harper; Terez Shea-Donohue; Eileen M Barry; James B Kaper; Alessio Fasano; James P Nataro
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

4.  Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations.

Authors:  Dilara Islam; Nattaya Ruamsap; Patchariya Khantapura; Ajchara Aksomboon; Apichai Srijan; Boonchai Wongstitwilairoong; Ladaporn Bodhidatta; Montip Gettayacamin; Malabi M Venkatesan; Carl J Mason
Journal:  APMIS       Date:  2013-09-13       Impact factor: 3.205

5.  In vitro antibacterial and time-kill assessment of crude methanolic stem bark extract of Acacia mearnsii de wild against bacteria in shigellosis.

Authors:  Olufunmiso Olusola Olajuyigbe; Anthony Jide Afolayan
Journal:  Molecules       Date:  2012-02-21       Impact factor: 4.411

6.  Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection.

Authors:  Mabel Lum; Stephen R Attridge; Renato Morona
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

7.  Pathogenicity of Shigella in chickens.

Authors:  Run Shi; Xia Yang; Lu Chen; Hong-tao Chang; Hong-ying Liu; Jun Zhao; Xin-wei Wang; Chuan-qing Wang
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

8.  An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype.

Authors:  Jiro Mitobe; Ritam Sinha; Soma Mitra; Dhrubajyoti Nag; Noriko Saito; Ken Shimuta; Nobuo Koizumi; Hemanta Koley
Journal:  PLoS Negl Trop Dis       Date:  2017-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.